Methodological approaches to the long-term study of antidepressants

European Psychiatry

Volumn 11, Issue 3, 1996, Pages 109-115

  Rouillon, F ^a   Steru, L ^b   Wood, S ^b  

^a HÔPITAL LOUIS MOURIER   (France)

^b ITEM Labo   (France)

Author keywords

antidepressant; clinical trial; long term; methodology

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DIAZEPAM; FLUOXETINE; IMIPRAMINE; LITHIUM; MAPROTILINE; NOMIFENSINE; PAROXETINE; PHENELZINE; SERTRALINE;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECURRENCE RISK; RELAPSE; TREATMENT OUTCOME;

EID: 0029939652     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-9338(96)85173-X     Document Type: Article

References (33)

1. Belsher G, Costello CG. Relapse after recovery from unipolar depression: a critical review. Psychol Bull 1988;104:84-96
2. Bialos D, Giller F, Jatlow P et al. Recurrence of depression after discontinuation of long-term amitriptyline treatment. Am J Psychiatry 1982;139:325-9
3. Coppen A, Ghose K, Montgomery S et al. Continuation therapy with amitriptyline in depression. Br J Psychiatry1978;133:28-33
4. Doogan D, Caillard V. Sertraline in the prevention of depression. Br J Psychiatry 1992;160:217-22
5. Dunbar GC, Mewetts S. A double-blind comparative study of paroxetine and placebo in preventing recurrent major depressive episodes. Presented at the British Assoc of Psychopharmacology Annual meeting, York, 1991
6. Frank E, Kupfer DJ, Perel JM et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47:1093-9
7. Glen AIM, Johnson AL, Shepherd M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind controlled trial. Psychol Med 1984;14:37-50
8. Grof P. Designing long term clinical trials in affective disorders. J Affect Disord 1994;30:243-55
9. Harrison W, Rabkin J, Stewart JW et al. Phenelzine for chronic depression: a study of continuation treatment. J Clin Psychiatry 1986;47:346-9
10. Jonsson B, Bebbington P. Health economics of depression. In: Jonsson B, Rosenbaum J, eds. Perspectives in Psychiatry, Vol 4. Chichester, England: John Wiley 1993;35-48
11. Kane JM, Quitkin FM, Rifkin A et al. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar I illness. Arch Gen Psychiatry, 1982;39:1065-9
12. Kay DWK, Fahy T, Garside RF. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 1970;117:667-71
13. Klerman GL, Di Mascio A, Weissman MM et al. Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974;131:186-91
14. Kraepelin E. Das Manisch-Depressive irresein. In: Psychiatrie. Ein Lehrbuch für Studierende and Aerzte, vol III, 2. Leipzig, Germany: Barth, 1913
15. Kupfer DJ, Frank E. The minimum length of treatment for recovery. In: Montgomery SA, Rouillon F, eds. Long-term Treatment of Depression. London: John Wiley & Sons Ltd 1992;33-52
16. Kupfer DJ, Frank E, Perel JM et al. Five year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992;49:769-73
17. Lendresse P, Cren MC, Lemarie JC. Traitement prolongé par nomifensine 75 mg dans les états dépressifs névrotiques et réactionnels. Psychiatrie Française 1984;16 (suppl):156-8
18. Loonen AJN, Zwanikken GJ. Continuation and maintenance therapy with antidepressive agents: an overview of research. Phar Weekbl (Sci) 1990;12:128-41
19. Mindham RHS, Howland C, Shepherd M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 1973;3:5-17
20. Montgomery SA, Dufour H, Brion S et al. The prophylactic efficacy of fluoxetin in unipolar depression. Br J Psychiatry 1988;153 (3 suppl):69-76
21. Montgomery SA, Green M, Baldwin D, Montgomery D. Prophylactic treatment of depression: A public health issue. Neuropsycholiology 1989;22:214-9
22. Montgomery SA, Montgomery DB. Prophylactic treatment in recurrent unipolar depression. In: Montgomery SA, Rouillon F, eds. Long-Term Treatment of Depression. London: John Wiley & Sons Ltd 1992;53-79
23. Montgomery SA, Rasmussen TGC. Citalopram 20 mg, Citalopram 40 mg and placebo in the prevention of relapses of major depression. Int Clin Psychopharmacol 1991;6 (suppl 5):71-3
24. NIH/NIMH. Consensus development conference statement. Mood disorders: Pharmacologic Prevention of Recurrences. Consensus Development Panel. Am J Psychiatry 1985;142/4:469-76
25. Okuma T, Inanaga K, Otsuki S. A preliminary double blind study on the efficacy of carbamazepine in prophylaxis of manic depressive illness. Psychopharmacology 1981;73:95-6
26. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: analysis and examples. Br J Cancer 1977;35:1-39
27. Prien R, Kupfer DJ, Mansky PA et al. Drug therapy in the prevention of recurrence in unipolar and bipolar affective disorders. Arch Gen Psychiatry 1984;41:1096-104
28. Rouillon F, Serrurier D, Miller HD, Gérard MJ. Prophylactic efficacy of maprotiline on unipolar depression relapse. J Clin Psychiatry 1991;52/10:423-31
29. Rouillon F, Lejoyeux M, Filteau MJ. Unwanted effects of long term treatment. In: Montgomery SA, Rouillon F, eds. Long-Term Treatment of Depression. London: John Wiley & Sons 1992;81-112
30. Seager CP, Bird RL. Imipramine with electrical treatment in depression: a controlled trial. J Ment Sci 1962;108:704-7
31. Stein M, Rickels K, Weise CC. Maintenance therapy with amitriptyline: a controlled trial. Am J Psychiatry 1980;137:370-1
32. Thase ME. Relapse and recurrence in unipolar major depression. Short-term and long-term approaches. J Clin Psychiatry 1990;51;6 (suppl):51-7
33. Van Praag H, De Haan S. Depression vulnerability and 5-HT prophylaxis. Psychiatry Res 1980;3:75-83